Technological advancement in aiding the healthcare sector for the development of highly efficient and advanced treatments that provide faster relief from various medical conditions. Osseointegration implant is a type of implant that is used for creating a direct functional and structural connection between the bone and the surface of the artificial implant.
With rise in geriatric population and increasing popularity of cosmetic dentistry, the global osseointegration implants market is anticipated to expand at a notable CAGR of 6.4% during the forecast period of 2017-2023 and reach the valuation of USD 6.8 Bn by the end of 2023 from USD 4.7 Bn in 2017.
The development of osseointegration technique has enhanced the bone and joint replacement procedures along with dental implants and has improved prosthetics for amputees. Utilization of different types of materials to carry out the procedure and ability to provide stability to the implants and prostheses are propelling the growth of the global osseointegration implants market. However, complications and risks of bone damage associated with the implants and challenges faced during the alignment of implants are likely to restrain the expansion of the global osseointegration implants market during the forecast period.
Companies Covered
The key players operating in the Global Osseointegration Implants Market are Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Danaher Corporation, The Straumann Group, Henry Schein Inc., Stryker Corporation, NuVasive, Inc., William Demant Holding A/S, Cochlear Ltd., and Medtronic plc.
Segmental Analysis
For the scope of the research report, MRFR offers an in-depth analysis of the global osseointegration implants market